See more : Nabaltec AG (NTG.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Spectral AI, Inc. (MDAI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Spectral AI, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Dynamic Technologies Group Inc. (ERILF) Income Statement Analysis – Financial Results
- Canon Inc. (CAJFF) Income Statement Analysis – Financial Results
- Tabula Rasa HealthCare, Inc. (TRHC) Income Statement Analysis – Financial Results
- Car Mate Mfg. Co., Ltd. (7297.T) Income Statement Analysis – Financial Results
- Austerlitz Acquisition Corporation I (AUS-UN) Income Statement Analysis – Financial Results
Spectral AI, Inc. (MDAI)
About Spectral AI, Inc.
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 18.06M | 25.37M | 15.24M |
| Cost of Revenue | 10.18M | 14.53M | 8.19M |
| Gross Profit | 7.88M | 10.84M | 7.05M |
| Gross Profit Ratio | 43.64% | 42.72% | 46.28% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 20.86M | 13.48M | 11.23M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 20.86M | 13.48M | 11.23M |
| Other Expenses | 0.00 | 49.00K | 0.00 |
| Operating Expenses | 20.86M | 13.48M | 11.23M |
| Cost & Expenses | 31.04M | 28.02M | 19.42M |
| Interest Income | 172.00K | 21.00K | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 722.00K | 568.00K | 1.00K |
| EBITDA | -12.26M | -2.08M | -4.18M |
| EBITDA Ratio | -67.91% | -7.42% | -28.14% |
| Operating Income | -12.98M | -2.65M | -4.18M |
| Operating Income Ratio | -71.91% | -10.43% | -27.42% |
| Total Other Income/Expenses | -7.86M | -159.00K | 93.00K |
| Income Before Tax | -20.84M | -2.81M | -4.09M |
| Income Before Tax Ratio | -115.44% | -11.06% | -26.81% |
| Income Tax Expense | 11.00K | 106.00K | -98.00K |
| Net Income | -20.85M | -2.91M | -3.99M |
| Net Income Ratio | -115.50% | -11.48% | -26.17% |
| EPS | -1.48 | -0.16 | -0.22 |
| EPS Diluted | -1.48 | -0.16 | -0.22 |
| Weighted Avg Shares Out | 14.09M | 17.88M | 17.88M |
| Weighted Avg Shares Out (Dil) | 14.09M | 17.88M | 17.88M |
Spectral AI hails progress towards first sales and pre-FDA clinical trial
Spectral AI Inc (NASDAQ:MDAI) hailed progress in the first quarter towards first commercial product revenue later this year, along with strengthening of the management team and financial position. The developer of the DeepView wound imaging system reported research & development...
Spectral AI Announces 2024 First Quarter Financial Results
Q1 Overview Research & Development Revenue of $6.3 Million Improved Capital Structure Reflected in Cash of $10.2 Million DeepView AI®-Burn Devices Deployed in UK; Expect Commercial Revenue in 2H 2024 Additional Regulatory Submissions in US and UK for DeepView™ System...
Spectral AI to Participate at the Sidoti Micro-Cap Virtual Investor Conference
DALLAS, May 02, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that management...
Spectral AI receives TMAC Quality Achievement Award for wound care technology
Spectral AI Inc (NASDAQ:MDAI) announced it has been awarded the Commitment to Quality Achievement Award from the Texas Manufacturer Assistance Center (TMAC) for its UK Conformity Assessed (UKCA) Mark Attainment. The Dallas-based company is advancing its DeepView technology, a predictive...
Spectral AI Awarded Quality Achievement Award from the Texas Manufacturer Assistance Center
DALLAS, April 30, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that the...
Spectral AI Schedules 2024 First Quarter Financial Results and Conference Call
DALLAS, April 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it...
Spectral AI appoints Erich Spangenberg as CEO of Spectral IP
Spectral AI Inc (NASDAQ:MDAI) has appointed Erich Spangenberg to lead its health care IP-focused subsidiary, Spectral IP. Spangenberg, Spectral AI's largest shareholder, brings decades of experience in global IP investment and monetization.
Spectral AI appoints Erich Spangenberg as CEO of Spectral IP
Spectral AI Inc (NASDAQ:MDAI) has appointed Erich Spangenberg to lead its health care IP-focused subsidiary, Spectral IP. Spangenberg, Spectral AI's largest shareholder, brings decades of experience in global IP investment and monetization.
Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary
Spangenberg brings significant IP monetization experience and the potential to unlock additional value for Spectral AI shareholders Spangenberg brings significant IP monetization experience and the potential to unlock additional value for Spectral AI shareholders
Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer
Experienced Burn Industry Executive Champions Pivot to Commercialization Experienced Burn Industry Executive Champions Pivot to Commercialization
Source: https://incomestatements.info
Category: Stock Reports